Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study

Clinical trial NCT06929169 · RECRUITING

Trial details

NCT number: NCT06929169
Sponsor: Maximo Agustin Schiavone
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Kidney Disease Requiring Hemodialysis

Start date: 2025-05-01
Primary completion: 2026-07-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.